ROYALTY PHARMA PLC shareholders Q2 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
GLENMEDE TRUST CO NA 36,617$1,319,3100.01%
Lee Financial Co 1,300$39,9620.01%
Daiwa Securities Group Inc. 32,986$1,0140.01%
Parallax Volatility Advisers, L.P. 100,000$3,074,0000.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 44,696$1,3740.01%
CAPTRUST FINANCIAL ADVISORS 61,665$1,895,5820.01%
TD ASSET MANAGEMENT INC 194,457$5,977,6080.01%
UBS Group AG 689,743$21,202,7000.01%
INTECH INVESTMENT MANAGEMENT LLC 18,887$580,5870.01%
Invesco Ltd. 689,948$21,209,0010.01%
ACADIAN ASSET MANAGEMENT LLC 46,767$1,4360.01%
Echo Street Capital Management LLC 21,689$666,7200.01%
NATIONAL BANK OF CANADA /FI/ 98,511$3,025,3020.01%
Wealthfront Advisers LLC 45,348$1,393,9980.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 39,143$1,203,2560.01%
PFS Partners, LLC 203$6,2520.01%
XPONANCE, INC. 13,128$403,5550.01%
SG Americas Securities, LLC 23,644$7270.01%
BANK OF MONTREAL /CAN/ 429,874$13,820,4480.01%
Allianz Asset Management GmbH 85,256$2,620,7690.01%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.